enVVeno Medical/$NVNO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About enVVeno Medical
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Ticker
$NVNO
Sector
Primary listing
Industry
Health Care Equipment and Supplies
Headquarters
Employees
37
Website
enVVeno Medical Metrics
BasicAdvanced
$85M
-
-$1.17
0.81
-
Price and volume
Market cap
$85M
Beta
0.81
52-week high
$5.62
52-week low
$2.03
Average daily volume
123K
Financial strength
Current ratio
23.768
Quick ratio
23.444
Long term debt to equity
1.59
Total debt to equity
2.556
Profitability
EBITDA (TTM)
-23.103
Management effectiveness
Return on assets (TTM)
-34.07%
Return on equity (TTM)
-52.88%
Valuation
Price to book
2.22
Price to tangible book (TTM)
2.22
Price to free cash flow (TTM)
-5.086
Free cash flow yield (TTM)
-19.66%
Free cash flow per share (TTM)
-0.952
Growth
Earnings per share change (TTM)
-29.42%
3-year earnings per share growth (CAGR)
-16.56%
What the Analysts think about enVVeno Medical
Analyst ratings (Buy, Hold, Sell) for enVVeno Medical stock.
enVVeno Medical Financial Performance
Revenues and expenses
enVVeno Medical Earnings Performance
Company profitability
enVVeno Medical News
AllArticlesVideos
enVVeno Medical Participates in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference
Accesswire·1 week ago
Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting
Accesswire·2 months ago
enVVeno Medical Appoints Jennifer Bright as Chief Financial Officer
Accesswire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for enVVeno Medical stock?
enVVeno Medical (NVNO) has a market cap of $85M as of July 31, 2025.
What is the P/E ratio for enVVeno Medical stock?
The price to earnings (P/E) ratio for enVVeno Medical (NVNO) stock is 0 as of July 31, 2025.
Does enVVeno Medical stock pay dividends?
No, enVVeno Medical (NVNO) stock does not pay dividends to its shareholders as of July 31, 2025.
When is the next enVVeno Medical dividend payment date?
enVVeno Medical (NVNO) stock does not pay dividends to its shareholders.
What is the beta indicator for enVVeno Medical?
enVVeno Medical (NVNO) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.